Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
Eisai Inc.
PMV Pharmaceuticals, Inc
Mayo Clinic
Genmab
Genmab
Eli Lilly and Company
Terremoto Biosciences Inc.
Genmab
AstraZeneca
AstraZeneca
DualityBio Inc.
Radiopharm Theranostics, Ltd
Second Life Therapeutics
Tanabe Pharma America, Inc.
Avenzo Therapeutics, Inc.
Volastra Therapeutics, Inc.
LigaChem Biosciences, Inc.
Bolt Biotherapeutics, Inc.
Incyte Corporation
Cancer Research UK
858 Therapeutics, Inc.
NuCana plc
ModeX Therapeutics, An OPKO Health Company
Klus Pharma Inc.
Aminex Therapeutics, Inc.
Innolake Biopharm
NextCure, Inc.
Incyte Corporation
Incyte Corporation
Gilead Sciences
Novartis
NKGen Biotech, Inc.
Petra Pharma
Poveda, Andrés, M.D.
Otsuka Novel Products GmbH
Arno Therapeutics
National Cancer Institute (NCI)